1. Home
  2. PSN vs HALO Comparison

PSN vs HALO Comparison

Compare PSN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSN
  • HALO
  • Stock Information
  • Founded
  • PSN 1944
  • HALO 1998
  • Country
  • PSN United States
  • HALO United States
  • Employees
  • PSN N/A
  • HALO N/A
  • Industry
  • PSN EDP Services
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PSN Technology
  • HALO Health Care
  • Exchange
  • PSN Nasdaq
  • HALO Nasdaq
  • Market Cap
  • PSN 6.8B
  • HALO 7.4B
  • IPO Year
  • PSN 2019
  • HALO N/A
  • Fundamental
  • Price
  • PSN $68.25
  • HALO $52.02
  • Analyst Decision
  • PSN Buy
  • HALO Buy
  • Analyst Count
  • PSN 11
  • HALO 9
  • Target Price
  • PSN $87.44
  • HALO $63.56
  • AVG Volume (30 Days)
  • PSN 1.6M
  • HALO 3.1M
  • Earning Date
  • PSN 04-30-2025
  • HALO 05-06-2025
  • Dividend Yield
  • PSN N/A
  • HALO N/A
  • EPS Growth
  • PSN 50.29
  • HALO 55.40
  • EPS
  • PSN 2.35
  • HALO 3.76
  • Revenue
  • PSN $6,769,260,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • PSN $5.09
  • HALO $24.79
  • Revenue Next Year
  • PSN $4.47
  • HALO $22.65
  • P/E Ratio
  • PSN $29.35
  • HALO $13.83
  • Revenue Growth
  • PSN 16.61
  • HALO 25.64
  • 52 Week Low
  • PSN $54.56
  • HALO $41.28
  • 52 Week High
  • PSN $114.68
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • PSN 62.74
  • HALO 39.78
  • Support Level
  • PSN $63.07
  • HALO $47.50
  • Resistance Level
  • PSN $70.11
  • HALO $69.94
  • Average True Range (ATR)
  • PSN 2.34
  • HALO 3.52
  • MACD
  • PSN 0.24
  • HALO -1.49
  • Stochastic Oscillator
  • PSN 74.15
  • HALO 19.64

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: